US Broker Ratings

Talkspace, Inc. (TALK) Stock Analysis: An 80% Potential Upside in the Expanding Virtual Healthcare Market

Investors looking for opportunities in the burgeoning field of digital health services might find Talkspace, Inc. (NASDAQ: TALK) particularly intriguing. The company, which specializes in virtual behavioral healthcare, has been..

Vir Biotechnology, Inc. (VIR) Stock Analysis: Evaluating a Potential 230% Upside Despite Current Challenges

Vir Biotechnology, Inc. (NASDAQ: VIR) is a clinical-stage biopharmaceutical company that has positioned itself at the forefront of combating infectious diseases, with a rich pipeline that includes investigational therapies for..

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: High Growth Potential with a 242% Upside

Spyre Therapeutics, Inc. (SYRE), a clinical-stage biotechnology firm, is gaining significant attention from investors due to its promising pipeline in the treatment of inflammatory bowel disease (IBD) and its impressive..

Regulus Therapeutics Inc. (RGLS) Stock Analysis: Navigating a Promising Biotech Landscape Amidst Potential Downside

Regulus Therapeutics Inc. (NASDAQ: RGLS), a niche player in the biotechnology sector, has been capturing investor interest with its specialized focus on genetically based orphan diseases. Based in San Diego,..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Insights Into an 88.21% Upside Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), a biotechnology firm focused on developing groundbreaking treatments for neurodegenerative and endocrine disorders, presents an intriguing investment opportunity with a potential upside of 88.21%, according..

Avanos Medical, Inc. (AVNS): Investor Outlook on its Challenging Valuation and Recovery Prospects

Avanos Medical, Inc. (NYSE: AVNS) stands at an intriguing crossroads, positioned within the healthcare sector and specializing in innovative medical device solutions. Despite its pivotal role in providing essential products..

LifeMD, Inc. (LFMD) Stock Analysis: A Healthcare Innovator with Substantial Revenue Growth and Analyst Confidence

LifeMD, Inc. (NASDAQ: LFMD), a burgeoning player in the healthcare sector, is making waves with its innovative approach to telehealth and impressive financial performance. Based in New York, LifeMD operates..

Bicycle Therapeutics (BCYC) Stock Analysis: Evaluating a 253.60% Potential Upside in Biotechnology

In the dynamic world of biotechnology, Bicycle Therapeutics plc (NASDAQ: BCYC) is making waves with its innovative approach to drug development. Headquartered in Cambridge, UK, this clinical-stage company is pioneering..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Aiming for a 62% Upside in Pediatric Orthopedic Innovation

OrthoPediatrics Corp. (NASDAQ: KIDS), a leading innovator in pediatric orthopedic medical devices, continues to attract investor interest with its potential for substantial growth. As of the latest market data, the..

Fulgent Genetics, Inc. (FLGT) Investor Outlook: Navigating the Diagnostic Leader’s Growth Amidst Market Dynamics

Fulgent Genetics, Inc. (NASDAQ: FLGT), a significant player in the healthcare sector, operates within the diagnostics and research industry, providing cutting-edge clinical diagnostic and therapeutic development solutions. With a market..

Cogent Biosciences, Inc. (COGT) Stock Analysis: Unveiling a 113% Potential Upside

In the dynamic realm of biotechnology, Cogent Biosciences, Inc. (NASDAQ: COGT) is garnering significant investor attention with its eye-catching potential upside of 113.72%. As a trailblazer in precision therapies for..

Oculis Holding AG (OCS) Stock Analysis: Exploring a 102.84% Potential Upside in Eye-Care Innovation

Investors seeking opportunities in the biotechnology sector might find Oculis Holding AG (OCS) a compelling prospect. As a clinical-stage biopharmaceutical company based in Zug, Switzerland, Oculis is focused on developing..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking a 201% Potential Upside for Patient Investors

Tyra Biosciences, Inc. (NASDAQ: TYRA) is capturing the attention of investors intrigued by its promising growth prospects in the biotechnology sector. With a market cap of $531.78 million, this Carlsbad,..

InMode Ltd. (INMD) Stock Analysis: A Look at Potential Upside with Strong Return on Equity

InMode Ltd. (NASDAQ: INMD), a prominent player in the healthcare sector, specializes in the medical devices industry, offering innovative minimally invasive aesthetic medical products. With its headquarters in Yokne’am, Israel,..

InnovAge Holding Corp. (INNV) Stock Analysis: Exploring a 12% Potential Upside for Investors

InnovAge Holding Corp. (NASDAQ: INNV) operates at the intersection of healthcare and elder care, serving the senior community with a comprehensive suite of medical and ancillary services. As the healthcare..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring a Potential 232.73% Upside Amidst Strong Analyst Confidence

For investors seeking opportunities in the biotech sector, Arcus Biosciences, Inc. (NASDAQ: RCUS) stands out with its significant potential upside and strong analyst support. Despite recent challenges, including a substantial..

AxoGen, Inc. (AXGN) Stock Analysis: Unveiling a Potential 122% Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a prominent player in the medical devices industry, is making waves with its innovative approach to peripheral nerve regeneration. With a market capitalization of $497.8 million,..

Eton Pharmaceuticals, Inc. (ETON) Growth Potential: Rare Disease Focus with Over 105% Upside

Eton Pharmaceuticals, Inc. (ETON), a burgeoning entity in the healthcare sector, is making waves with its focus on developing and commercializing treatments for rare diseases. With its headquarters in Deer..

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Unveiling a Potential 211% Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) presents an intriguing opportunity for investors willing to navigate the high-risk, high-reward landscape of biotechnology stocks. With a current market cap of $312.44 million and..

HealthStream, Inc. (HSTM) Stock Analysis: Unpacking a 24.10% Potential Upside

HealthStream, Inc. (HSTM), a notable player in the healthcare information services sector, presents an intriguing investment opportunity for those looking to capitalize on technological advancements in healthcare. Headquartered in Nashville,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds